Open Demat Account
Become a
New
Partner
Products &
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Bliss GVS Pharma Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
121.84
122.25
Date :
Apr 29,2025 09:54:55
+0.30
(0.25 )
+0.45
(0.55 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
123.00
Buy (size)
121.95(x8)
Sell (size)
122.08(×17)
Buy Qty
8
Sell Qty
17
Today's High
(₹)
124.01
Today's Low
(₹)
121.51
52 Week High
(₹)
185.50
52 Week Low
(₹)
92.15
Market Statistics
Div Yield (%)
0.41
EPS
7.7
Book Value
95.85
Market Cap
1282.36
Face Value
1
Market Lot
1
AGM Date
Jul
Closure Date
Jul
ISIN No
INE416D01022
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
37187174
Total of Promoter
37187174
Non Promoter (Institution)
20791641
Non Promoter (Non-Institution)
47391457
Total Non Promoter
68183098
Total Promoter & Non Promoter
105370272
Custodians(Against Depository Receipts)
0
Grand Total
105370272
News
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
23-Apr-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Updates
Bliss GVS Pharma Limited has informed the Exchange regarding Intimation of change in contact details of MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company. .
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Intimation Under Regul..
15-Apr-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015.
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you that the Rising Pharma Holdings Inc. USA a marketing and distribution partner of bliss GVS Pharma Limited ('the Company') has been granted final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for its product 'Mesalamine Suppositories 1000 mg'. The ANDA was submitted through our partner in the USA.
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
15-Apr-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Updates
Bliss GVS Pharma Limited has informed the Exchange regarding Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015, we would like to inform you that the Rising Pharma Holdings, Inc. USA, a marketing and distribution partner of Bliss GVS Pharma Limited ( the Company ) has been granted final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for its product Mesalamine Suppositories 1000 mg . The ANDA was submitted through our partner in the USA..
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
15-Apr-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Other General Purpose
Bliss GVS Pharma Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Pendency Of Litigation..
12-Apr-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Pendency Of Litigation(S)/Dispute(S)
This is a continuation of our communication dated March 26 2021 regarding the commercial suit for infringement of Intellectual Property Rights. We previously informed you that Bliss GVS Pharma Limited ('the Company') had filed a suit in the High Court of Justice Ghana in its Commercial Division against the infringing party ('the Defendant') concerning the illegal manufacture of the Companys registered trademark by the Defendant. Please find enclosed herewith the intimation about the decision on commercial suit for infringement of intellectual property rights.
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
28-Mar-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Change in Management
Bliss GVS Pharma Limited has informed the Exchange about change in Management
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
27-Mar-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Trading Window
Bliss GVS Pharma Limited has informed the Exchange about Closure of Trading Window
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Closure of Trading Win..
26-Mar-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Closure of Trading Window
Please find enclosed herewith the intimation regarding closure of Trading Window.
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limit..
26-Mar-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Trading Window
Bliss GVS Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Disclosures under Reg...
24-Mar-2025
Read More
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vibha Gagan Sharma & PACs
Corporate Details
Board of Directors
Incorporation Year
1984
Chairman
Nandkumar Kashinath Chodankar
Auditor
Kalyaniwalla & Mistry LLP
Face Value
1
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
6/29A Udit Mittal Industry Andheri Kurla Road Andheri (East) MR Maharashtra Mumbai400059
Contact
Telephone: 91-22-42160000
Fax: 91-22-28563930
Whole-time Director
Vibha G Sharma
Shruti Vishal Rao
Non-Exec. & Independent Dir.
Santosh Parab
Company Sec. & Compli. Officer
Aditi Bhatt
Non-Exec. & Independent Dir.
Shilpa Bhatia
Managing Director
Gagan Harsh Sharmma
Chairman
Nandkumar Kashinath Chodankar
Mutual Fund Holdings
1-2
of 2
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Motilal Oswal BSE Healthcare ETF
0.02
0.06
27.77
Bandhan BSE Healthcare Index Fund
0.01
0.06
17.34
FAQ
What is the share price of Bliss GVS Pharma Ltd today on NSE and BSE?
The Bliss GVS Pharma Ltd Share price on NSE is Rs.121.84 and BSE Rs.122.25 as on today
How to buy Bliss GVS Pharma Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Bliss GVS Pharma Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Bliss GVS Pharma Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Bliss GVS Pharma Ltd is 1282.36
What are the key financial ratios to analyse Bliss GVS Pharma Ltd Share Price?
Bliss GVS Pharma Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 15.81
ROE ratio: 7.91
Debt to Equity ratio: 0.08
EPS: 7.7
When did Bliss GVS Pharma Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Bliss GVS Pharma Ltd issued bonus shares last in 2008
What is the 52 week highest and lowest share price value of Bliss GVS Pharma Ltd?
The highest share price value is Rs. 185.50 and Lowest share price value is Rs. 92.15 for 52 week period for Bliss GVS Pharma Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Bliss GVS Pharma Ltd?
Motilal Oswal BSE Healthcare ETF has the highest amount invested with Bliss GVS Pharma Ltd.
Which year Bliss GVS Pharma Ltd was incorporated?
Bliss GVS Pharma Ltd was incorporated in 1984
What is the stock symbol of Bliss GVS Pharma Ltd?
The stock symbol for Bliss GVS Pharma Ltd shares is BLISSGVSPHARMALTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Ajanta Pharma Ltd
532331
AJANTPHARM
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Ankur Drugs & Pharma Ltd
531683
ANKURDRUGS
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
28 Apr 2025
3,09,528.00
1,18,034.00
38.13
25 Apr 2025
6,97,055.00
2,74,438.00
39.37
24 Apr 2025
18,78,294.00
5,42,081.00
28.86
23 Apr 2025
2,05,552.00
89,423.00
43.50
22 Apr 2025
2,55,659.00
1,16,220.00
45.46
21 Apr 2025
2,31,215.00
1,00,260.00
43.36
17 Apr 2025
3,34,016.00
1,58,221.00
47.37
16 Apr 2025
3,25,527.00
1,56,506.00
48.08
15 Apr 2025
3,43,029.00
1,48,161.00
43.19
11 Apr 2025
1,77,022.00
66,474.00
37.55
09 Apr 2025
1,73,831.00
79,577.00
45.78
08 Apr 2025
2,29,520.00
86,576.00
37.72
07 Apr 2025
4,34,071.00
1,56,288.00
36.01
04 Apr 2025
3,36,993.00
1,36,181.00
40.41
03 Apr 2025
8,31,569.00
2,67,972.00
32.22
02 Apr 2025
1,65,443.00
60,279.00
36.43
01 Apr 2025
1,99,995.00
72,190.00
36.10
Please wait ...